Breaking Finance News

Acadia Healthcare Company (NASDAQ:ACHC) price target dropped to $59.00, issued a research note today by RBC Capital Markets

Displaying a price of $45.19, Acadia Healthcare Company (NASDAQ:ACHC) traded 4.03% higher on the day. With the last stock price down -17.11% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the date range. Acadia Healthcare Company has recorded a 50-day average of $49.05 and a two hundred day average of $54.52. Volume of trade was up over the average, with 1,267,467 shares of ACHC changing hands over the typical 1,034,080

In a report announced on Wednesday October 19, 2016 RBC Capital Markets lowered the target price of Acadia Healthcare Company (NASDAQ:ACHC) from $78.00 to $59.00 stating a potential upside of 0.31%.

Recent Performance Chart

Acadia Healthcare Company (NASDAQ:ACHC)

Acadia Healthcare Company has PE ratio of 24.14 with a 52 week low of $42.47 and a 52 week high of $74.77 and has a total market value of $0.

A total of 16 firms have reported on the stock. 7 brokers rating the stock a strong buy, 9 brokers rating the stock a buy, one analyst rating the company a hold, zero brokerages rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $79.19.

More About Acadia Healthcare Company (NASDAQ:ACHC)

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico. The Company operates approximately 260 behavioral healthcare facilities with over 9,900 beds in over 40 states, the United Kingdom and Puerto Rico. Its U.S. facilities and services are classified into categories, which include acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers and outpatient community-based services. It provides inpatient services through mental health hospitals and care homes in the United Kingdom.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.